Marco Binder

6.4k total citations · 1 hit paper
56 papers, 3.9k citations indexed

About

Marco Binder is a scholar working on Immunology, Hepatology and Epidemiology. According to data from OpenAlex, Marco Binder has authored 56 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 22 papers in Hepatology and 17 papers in Epidemiology. Recurrent topics in Marco Binder's work include interferon and immune responses (30 papers), Hepatitis C virus research (20 papers) and Immune Response and Inflammation (14 papers). Marco Binder is often cited by papers focused on interferon and immune responses (30 papers), Hepatitis C virus research (20 papers) and Immune Response and Inflammation (14 papers). Marco Binder collaborates with scholars based in Germany, France and United States. Marco Binder's co-authors include Ralf Bartenschlager, Darius Moradpour, Joseph Curran, Kay Hofmann, Etienne Meylan, Jürg Tschopp, Volker Lohmann, Florian Eberle, Joschka Willemsen and Lars Kaderali and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Marco Binder

52 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

2005 2.0k citations Marco Binder, Ralf Bartenschlager et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Binder Germany	24	2.6k	1.3k	1.2k	1.1k	696	56	3.9k
Eileen Foy United States	8	2.9k 1.1×	995 0.7×	1.9k 1.6×	2.1k 2.0×	695 1.0×	9	4.6k
William M. Schneider United States	20	2.2k 0.9×	1.6k 1.2×	943 0.8×	332 0.3×	1.4k 2.0×	33	4.4k
Rashu B. Seth United States	8	3.9k 1.5×	2.2k 1.6×	1.1k 0.9×	488 0.5×	827 1.2×	8	5.1k
Stacy M. Horner United States	34	1.2k 0.5×	2.7k 2.1×	870 0.8×	602 0.6×	506 0.7×	61	4.4k
Christine Neuveut France	31	870 0.3×	2.0k 1.5×	1.4k 1.2×	810 0.8×	369 0.5×	53	3.9k
Masanori Isogawa Japan	30	1.5k 0.6×	524 0.4×	2.7k 2.3×	2.2k 2.0×	618 0.9×	61	4.2k
Thomas Pertel United States	26	2.0k 0.8×	1.1k 0.8×	853 0.7×	222 0.2×	597 0.9×	37	3.5k
Michael D. Robek United States	29	1.5k 0.6×	396 0.3×	1.4k 1.2×	936 0.9×	463 0.7×	55	2.8k
Krishna K. Murthy United States	30	1.4k 0.6×	947 0.7×	3.0k 2.6×	3.1k 2.9×	852 1.2×	73	5.6k
Meike Dittmann United States	15	1.8k 0.7×	1000 0.7×	859 0.7×	123 0.1×	1.2k 1.7×	26	3.4k

Countries citing papers authored by Marco Binder

Since Specialization

Citations

This map shows the geographic impact of Marco Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Binder more than expected).

Fields of papers citing papers by Marco Binder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Binder. The network helps show where Marco Binder may publish in the future.

Co-authorship network of co-authors of Marco Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Binder. A scholar is included among the top collaborators of Marco Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Binder. Marco Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Betz, Andreas, Zuguang Gu, Matthias Schlesner, et al.. (2025). Reconstitution of interferon regulatory factor 7 expression restores interferon beta induction in Huh7 cells. Journal of Virology. 99(6). e0070325–e0070325.

Freistaedter, Andrew, Tobias Boettler, Marco Binder, et al.. (2025). Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome. Nature Communications. 16(1). 5403–5403. 1 indexed citations

Magalhães, Vladimir Gonçalves, Daniel Kirrmaier, Michael Knop, et al.. (2025). The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistent replication in cell culture. PLoS Pathogens. 21(9). e1013516–e1013516.

Binder, Marco, et al.. (2024). Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals. Current Opinion in Virology. 67. 101423–101423. 13 indexed citations

Müller, Christin, et al.. (2023). Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Archives of Virology. 168(2). 63–63. 1 indexed citations

Zitzmann, Carolin, Christopher Dächert, Bianca Schmid, et al.. (2023). Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies. PLoS Computational Biology. 19(4). e1010423–e1010423. 4 indexed citations

Sahle, Sven, Pascal Mutz, Christopher Dächert, et al.. (2022). Stochastic dynamics of Type-I interferon responses. PLoS Computational Biology. 18(10). e1010623–e1010623. 6 indexed citations

Sieg, Michael, et al.. (2022). The Interferon Response Dampens the Usutu Virus Infection-Associated Increase in Glycolysis. Frontiers in Cellular and Infection Microbiology. 12. 823181–823181. 8 indexed citations

Andersen, Line Lykke, Pietro Scaturro, Christopher Dächert, et al.. (2021). NUDT2 initiates viral RNA degradation by removal of 5′-phosphates. Nature Communications. 12(1). 6918–6918. 15 indexed citations

10.

Dächert, Christopher, Martijn J. van Hemert, Ali Taş, et al.. (2020). Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation. PLoS Computational Biology. 16(2). e1007587–e1007587. 7 indexed citations

11.

Maiwald, Tim, Marcel Schilling, Annette Schneider, et al.. (2020). Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses. PLoS Pathogens. 16(10). e1008461–e1008461. 6 indexed citations

12.

Rosenblatt, Marcus, Vladimir Gonçalves Magalhães, Christopher Dächert, et al.. (2020). Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction. Molecular Systems Biology. 16(7). e8955–e8955. 34 indexed citations

13.

Zitzmann, Carolin, Bianca Schmid, Alessia Ruggieri, et al.. (2020). A Coupled Mathematical Model of the Intracellular Replication of Dengue Virus and the Host Cell Immune Response to Infection. Frontiers in Microbiology. 11. 725–725. 22 indexed citations

14.

Hayman, Thomas J., Alan Hsu, Tatiana B. Kolesnik, et al.. (2019). RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses. Immunology and Cell Biology. 97(9). 840–852. 77 indexed citations

15.

Mutz, Pascal, Philippe Metz, Florian A. Lempp, et al.. (2018). HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Gastroenterology. 154(6). 1791–1804.e22. 126 indexed citations

16.

Esser‐Nobis, Katharina, Anna Reustle, Philipp Schult, et al.. (2015). DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture. Journal of Virology. 89(20). 10548–10568. 51 indexed citations

17.

Bender, Silke, et al.. (2015). Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus. PLoS Pathogens. 11(11). e1005264–e1005264. 130 indexed citations

18.

Wang, Hui, Sinéad Flannery, Sabine Dickhöfer, et al.. (2014). A Coding IRAK2 Protein Variant Compromises Toll-like receptor (TLR) Signaling and Is Associated with Colorectal Cancer Survival. Journal of Biological Chemistry. 289(33). 23123–23131. 17 indexed citations

19.

Stevenson, Nigel J., Nollaig M. Bourke, Elizabeth J. Ryan, et al.. (2013). Hepatitis C virus targets the interferon‐α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Letters. 587(10). 1571–1578. 45 indexed citations

20.

Binder, Marco, Florian Eberle, Stefan Seitz, et al.. (2011). Molecular Mechanism of Signal Perception and Integration by the Innate Immune Sensor Retinoic Acid-inducible Gene-I (RIG-I). Journal of Biological Chemistry. 286(31). 27278–27287. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact